 Connie Valdez
Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pharmacy | 2 | 2022 | 32 | 1.370 |
Why?
| | Students, Pharmacy | 6 | 2024 | 97 | 1.110 |
Why?
| | Education, Pharmacy | 5 | 2024 | 120 | 0.870 |
Why?
| | Pharmacy Service, Hospital | 2 | 2022 | 90 | 0.750 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2024 | 2531 | 0.730 |
Why?
| | Prescription Drugs | 1 | 2022 | 109 | 0.670 |
Why?
| | Pharmacies | 1 | 2020 | 38 | 0.650 |
Why?
| | Insulin | 3 | 2024 | 2409 | 0.640 |
Why?
| | Insulin Detemir | 1 | 2016 | 8 | 0.500 |
Why?
| | Ibuprofen | 1 | 2016 | 84 | 0.500 |
Why?
| | Insulin Lispro | 1 | 2016 | 39 | 0.490 |
Why?
| | Nonprescription Drugs | 1 | 2016 | 63 | 0.490 |
Why?
| | Polypharmacy | 1 | 2016 | 85 | 0.480 |
Why?
| | Dietary Proteins | 1 | 2016 | 135 | 0.450 |
Why?
| | Caloric Restriction | 1 | 2016 | 124 | 0.450 |
Why?
| | Renal Insufficiency | 1 | 2016 | 162 | 0.440 |
Why?
| | Hypoglycemic Agents | 4 | 2024 | 1291 | 0.420 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 350 | 0.410 |
Why?
| | Bariatric Surgery | 1 | 2016 | 217 | 0.390 |
Why?
| | Pharmacists | 3 | 2022 | 265 | 0.350 |
Why?
| | Adipokines | 1 | 2009 | 49 | 0.310 |
Why?
| | Educational Measurement | 3 | 2016 | 289 | 0.290 |
Why?
| | Osteoporosis | 1 | 2009 | 243 | 0.250 |
Why?
| | Body Composition | 1 | 2009 | 684 | 0.240 |
Why?
| | Bone Density | 1 | 2009 | 489 | 0.230 |
Why?
| | Heptanoic Acids | 1 | 2005 | 66 | 0.230 |
Why?
| | Simvastatin | 1 | 2005 | 61 | 0.230 |
Why?
| | Health Maintenance Organizations | 1 | 2005 | 108 | 0.230 |
Why?
| | Hypolipidemic Agents | 1 | 2005 | 91 | 0.230 |
Why?
| | Hyperlipidemias | 1 | 2005 | 120 | 0.220 |
Why?
| | Self Concept | 1 | 2006 | 253 | 0.220 |
Why?
| | Pyrroles | 1 | 2005 | 213 | 0.220 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 1040 | 0.180 |
Why?
| | Patient Compliance | 1 | 2005 | 581 | 0.180 |
Why?
| | Ambulatory Care Facilities | 1 | 2022 | 232 | 0.160 |
Why?
| | United States | 5 | 2024 | 14841 | 0.160 |
Why?
| | Curriculum | 2 | 2024 | 992 | 0.160 |
Why?
| | Colorado | 5 | 2024 | 4565 | 0.150 |
Why?
| | Guatemala | 1 | 2020 | 327 | 0.150 |
Why?
| | Humans | 17 | 2024 | 137585 | 0.150 |
Why?
| | Retrospective Studies | 4 | 2024 | 15657 | 0.130 |
Why?
| | Community Pharmacy Services | 2 | 2007 | 45 | 0.130 |
Why?
| | Nephrology Nursing | 1 | 2016 | 14 | 0.130 |
Why?
| | Adult | 5 | 2024 | 37929 | 0.130 |
Why?
| | Drug Administration Routes | 1 | 2016 | 38 | 0.130 |
Why?
| | Health Services for the Aged | 1 | 2016 | 80 | 0.120 |
Why?
| | Drug Interactions | 1 | 2016 | 410 | 0.120 |
Why?
| | Pharmaceutical Preparations | 1 | 2015 | 179 | 0.100 |
Why?
| | Clinical Competence | 3 | 2016 | 1118 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1483 | 0.090 |
Why?
| | Patient-Centered Care | 1 | 2016 | 530 | 0.090 |
Why?
| | Schools, Pharmacy | 3 | 2024 | 47 | 0.090 |
Why?
| | Primary Health Care | 2 | 2020 | 1738 | 0.090 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2010 | 38 | 0.080 |
Why?
| | Prescriptions | 1 | 2010 | 67 | 0.080 |
Why?
| | Resistin | 1 | 2009 | 11 | 0.080 |
Why?
| | Biological Factors | 1 | 2009 | 39 | 0.080 |
Why?
| | Critical Illness | 1 | 2015 | 811 | 0.080 |
Why?
| | Economics, Pharmaceutical | 1 | 2008 | 9 | 0.080 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 201 | 0.070 |
Why?
| | Obesity | 2 | 2015 | 2992 | 0.070 |
Why?
| | Absorptiometry, Photon | 1 | 2009 | 259 | 0.070 |
Why?
| | Leptin | 1 | 2009 | 236 | 0.070 |
Why?
| | Costs and Cost Analysis | 1 | 2008 | 213 | 0.070 |
Why?
| | Hip Joint | 1 | 2009 | 171 | 0.070 |
Why?
| | Adiponectin | 1 | 2009 | 244 | 0.070 |
Why?
| | Lumbar Vertebrae | 1 | 2009 | 246 | 0.070 |
Why?
| | Accreditation | 1 | 2007 | 83 | 0.070 |
Why?
| | Aspirin | 1 | 2010 | 387 | 0.060 |
Why?
| | Cross-Sectional Studies | 2 | 2009 | 5472 | 0.060 |
Why?
| | Aged, 80 and over | 2 | 2016 | 7635 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2024 | 5778 | 0.060 |
Why?
| | Confidentiality | 1 | 2006 | 73 | 0.060 |
Why?
| | Middle Aged | 4 | 2016 | 33479 | 0.060 |
Why?
| | Preceptorship | 1 | 2006 | 66 | 0.060 |
Why?
| | Medical Audit | 1 | 2005 | 78 | 0.060 |
Why?
| | Female | 5 | 2024 | 73304 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2009 | 1242 | 0.050 |
Why?
| | Pilot Projects | 1 | 2009 | 1710 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1477 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2009 | 2828 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2005 | 548 | 0.040 |
Why?
| | Research Design | 1 | 2006 | 1139 | 0.040 |
Why?
| | Aged | 3 | 2010 | 23961 | 0.040 |
Why?
| | Vaccination | 1 | 2007 | 1381 | 0.040 |
Why?
| | Male | 4 | 2024 | 67762 | 0.030 |
Why?
| | Lung | 1 | 2009 | 4060 | 0.030 |
Why?
| | Pharmacokinetics | 1 | 2015 | 29 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2010 | 3715 | 0.030 |
Why?
| | Drug Prescriptions | 1 | 2015 | 245 | 0.030 |
Why?
| | Information Dissemination | 1 | 2015 | 218 | 0.020 |
Why?
| | Decision Support Systems, Clinical | 1 | 2015 | 226 | 0.020 |
Why?
| | Communication | 1 | 2016 | 879 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 985 | 0.020 |
Why?
| | Medication Therapy Management | 1 | 2010 | 76 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2010 | 227 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1329 | 0.020 |
Why?
| | Animals | 1 | 2008 | 36940 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2010 | 556 | 0.010 |
Why?
| | Immunization Programs | 1 | 2007 | 213 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2015 | 6079 | 0.010 |
Why?
| | Adolescent | 2 | 2015 | 21513 | 0.010 |
Why?
| | Infant | 1 | 2015 | 9465 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2010 | 1313 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 11074 | 0.010 |
Why?
| | Child | 1 | 2015 | 21935 | 0.010 |
Why?
| | Young Adult | 1 | 2010 | 13209 | 0.010 |
Why?
|
|
Valdez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|